Concordia Healthcare Corp. Company Profile (NASDAQ:CXRX)

Analyst Ratings

Consensus Ratings for Concordia Healthcare Corp. (NASDAQ:CXRX) (?)
Ratings Breakdown: 3 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $51.23 (178.86% upside)

Analysts' Ratings History for Concordia Healthcare Corp. (NASDAQ:CXRX)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016TD SecuritiesReiterated RatingBuy$45.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Royal Bank Of CanadaReiterated RatingOutperform$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016LaurentianReiterated RatingBuy$60.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016CIBCBoost Price TargetSector Performer$31.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Laurentian Bank of CanadaLower Price TargetBuy$60.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Dundee SecuritiesLower Price Target$46.50 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015MackieReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015ScotiabankReiterated RatingSector Outperform$80.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015S&P Equity ResearchReiterated RatingBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Howard WeilInitiated CoverageOutperform$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Concordia Healthcare Corp. (NASDAQ:CXRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/13/2016Q116$1.54$1.35$231.00 million$228.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/23/2016Q415$1.32$1.24$166.60 million$191.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315$1.43$1.46$93.11 million$94.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q215$0.91$0.96$84.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Concordia Healthcare Corp. (NASDAQ:CXRX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.35$1.35$1.35
Q2 20161$1.52$1.52$1.52
Q3 20161$1.62$1.62$1.62
Q4 20161$1.68$1.68$1.68
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Concordia Healthcare Corp. (NASDAQ:CXRX)
Annual Dividend:$0.30
Dividend Yield:1.63%
Payout Ratio:-34.09% (Based on Trailing 12 Months of Earnings)
4.41% (Based on Current Year Consensus EPS Estimate)
3.88% (Based on Next Year Consensus EPS Estimate)

Dividend History for Concordia Healthcare Corp. (NASDAQ:CXRX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/16/2016quarterly$0.081.03%7/13/20167/15/20167/29/2016Tweet This Announcement  Share This Announcement on StockTwits
3/24/2016quarterly$0.081.13%4/13/20164/15/20164/29/2016Tweet This Announcement  Share This Announcement on StockTwits
11/17/2015quarterly$0.080.92%1/13/20161/15/20161/29/2016Tweet This Announcement  Share This Announcement on StockTwits
8/14/2015quarterly$0.080.39%10/13/201510/15/201510/30/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Concordia Healthcare Corp. (NASDAQ:CXRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Concordia Healthcare Corp. (NASDAQ:CXRX)
DateHeadline
07/26/16 03:32 PMMontrusco Bolton Investments Lowers stake in Concordia Healthcare Corp (CXRX) - Trade Calls
07/25/16 08:19 PMConcordia: Tickets Might Get Expensive After August 12th
07/25/16 02:47 PMConcordia International Is A Sewer - Seeking Alpha
07/23/16 03:28 PMConcordia International Is A Sewer
07/23/16 07:12 AMEquity Roundup: Stock Performance Focus on Concordia Healthcare Corp (NASDAQ:CXRX) - Press Telegraph
07/21/16 07:00 AMConcordia Healthcare Corp (NASDAQ:CXRX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 07:00 AMBroker Outlook For Concordia Healthcare Corp. (NASDAQ:CXRX) - Fiscal Standard
07/19/16 01:00 PMConcordia International Announces Release Date for Second Quarter 2016 Results - [CNW Group] - Concordia International Announces Release Date for Second Quarter 2016 Results
07/19/16 09:40 AMNext Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX) - Fiscal Standard
07/14/16 06:16 AMConcordia Healthcare (CXRX) Provides Update on Brexit Impact - StreetInsider.com
07/13/16 04:02 PM5:02 pm Concordia provides additional disclosure in relation to Brexit's impact on its business -
07/13/16 04:00 PMConcordia International Corp. Provides Additional Disclosure in Relation to Brexit's Impact on its Business - [CNW Group] - Concordia International Corp. Provides Additional Disclosure in Relation to Brexit's Impact on its Business
07/13/16 03:39 PMConcordia Healthcare Corp (NASDAQ:CXRX) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 03:39 PMConcordia Healthcare Corp (NASDAQ:CXRX) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 03:42 PMWall Street Ratings and Target Price Views on Concordia Healthcare Corp (NASDAQ:CXRX) - Telanagana Press
07/11/16 08:20 AMConcordia: An LBO That Trades Publicly?
07/06/16 09:21 PMCan Concordia Healthcare Corp (NASDAQ:CXRX) Improve on the Earnings Front? - Engelwood Daily
07/01/16 08:39 PMConcordia Healthcare (NASDAQ:CXRX) receives FDA approval for its new Photofrin 630 PDT Laser: Shire (NASDAQ ... - KC Register
07/01/16 08:39 PMIs Selling Stock Like Concordia Healthcare Corp After Such Decline Winning Strategy? - Engelwood Daily
07/01/16 03:33 PM2 Contrarian Stocks for Outstanding Returns
06/30/16 08:54 PMFDA approves Concordia's new Photofrin laser - Seeking Alpha
06/30/16 08:54 PMConcordia Healthcare Corp. (NASDAQ:CXRX) Current Analyst Ratings - Fiscal Standard
06/30/16 08:54 PMConcordia Healthcare's (CXRX) PMA for Photofrin 630 PDT Laser Receives FDA Approval - StreetInsider.com
06/30/16 09:30 AMConcordia International Corp. : Announces FDA Approval for New Photofrin® Laser
06/30/16 09:30 AMConcordia Healthcare Gets FDA Approval for New Photofrin Laser
06/30/16 09:30 AMConcordia Healthcare's (CXRX) PMA for Photofrin 630 PDT Laser Receives FDA Approval
06/30/16 07:44 AMConcordia International Gets FDA Approval For New Photofrin Laser -
06/29/16 12:57 PMDiamond Resorts Stock (DRII) Soaring Over 20% Due to Merger Agreement -
06/28/16 08:26 AMCovering the Bases on Concordia Healthcare Corp (NASDAQ:CXRX): Where is the Stock Going? - Press Telegraph
06/28/16 08:26 AMConcordia Healthcare Is Worse Than Valeant - Seeking Alpha
06/28/16 08:26 AMConcordia Healthcare (CXRX) Changes Name to Concordia International, Comments on Brexit Impact - StreetInsider.com
06/27/16 08:00 AMConcordia Healthcare Is Worse Than Valeant
06/25/16 07:23 AMIs Selling Concordia Healthcare Corp Here a Winning Strategy? The Stock Just Gapped Down - Engelwood Daily
06/23/16 02:25 PMRecently Issued Stock Ratings For Concordia Healthcare Corp. (NASDAQ:CXRX) - Fiscal Standard
06/21/16 08:14 AMConcordia Healthcare Up 4% - Says Analysis of PDT with Photofrin Positive, To Pay $12.5 Mln to Settle Arbitration Proceeding
06/20/16 03:28 PMConcordia Healthcare Up 4% - Says Analysis of PDT with Photofrin Positive, To Pay $12.5 Mln to Settle Arbitration ... - Nasdaq
06/20/16 03:28 PMConcordia Healthcare Corp. (NASDAQ:CXRX) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 08:04 AMConcordia Healthcare Announces PDT with Photofrin® Data and Provides Corporate Update
06/17/16 04:11 PMETF’s with exposure to Concordia Healthcare Corp. : June 17, 2016 -
06/10/16 07:14 AMConcordia Healthcare sees upside bet -
06/08/16 09:16 AMMoody's: US Specialty Pharma's M&A focus shifts to pipelines and innovative products -
06/08/16 07:03 AMApollo Global (APO) Submits Bid to Acquire Concordia -
06/06/16 07:55 PMBenzinga's M&A Chatter for Monday June 6, 2016 - The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday June 6, 2016: Apollo Global Management Said to Still be in Talks to Acquire Concordia Healthcare The Rumor:Apollo Global Management LLC (NYSE: APO) is still in talks to acquire Concordia Healthcare Corp. (NASDAQ: CXRX), according to sources as reported by Dow Jones on Monday. While two other private-equity firms dropped out of the bidding process over regulatory concerns, Apollo submitted a bid in the final round, the sources said. Concordia Healthcare rose $0.18 Monday, to close at $26.71. ManpowerGroup to Acquire Dutch Business of Ciber for $25M in Cash The Deal:Ciber Nederland B.V., a subsidiary of Ciber, Inc. (NYSE: CBR) and ManpowerGroup Netherlands B.V. (NYSE: MAN) announced Monday, that they have signed a purchase agreement for the sale of certain of the assets and liabilities of Ciber Nederland. The purchase price is $25 million in cash purchase price, subject to a price adjustment related to the retention of certain Ciber Nederland customers, plus an escrow amount of $5.0 million of the purchase price. Manpower closed at $79.06 on Monday, up $0.27. eFuture Reports Preliminary Non-Binding Proposal from Shiji of $6.32/Share The Offer:eFuture Holding Inc. (NASDSThe following are the M&A deals, rumors and chatter circulating on Wall Street for Monday ...Full story available on Benzinga.com
06/06/16 03:22 PMApollo Still in Talks to Buy Concordia
06/06/16 02:34 PMHow Did Biotech ETFs Perform in the Week Ended June 3? -
06/06/16 07:49 AMThe Wall Street Journal: Apollo Global Management is still in talks to buy Concordia Healthcare - Apollo Global Management LLC is still in talks to buy Concordia Healthcare Corp. after two other private-equity firms walked away over concern that tighter regulatory scrutiny of pharmaceutical companies might hurt the Canadian pharmaceutical company’s earnings.
06/06/16 04:50 AMConcordia Healthcare Corporation (NASDAQ:CXRX) Short Interest Increased By 43.06% - HNN
06/05/16 10:13 AMWhy Did Concordia Healthcare Corp. Drop Over 20% Yesterday?
06/03/16 02:16 PMETF’s with exposure to Concordia Healthcare Corp. : June 3, 2016 -
06/03/16 10:40 AMConcordia Healthcare Corp (NASDAQ:CXRX) Stock Update & Estimates - Stock Tick Tock

Social

About Concordia Healthcare Corp.

Concordia Healthcare Corp. logoConcordia Healthcare Corp. is a Canada-based diverse healthcare company. The Company is focused on legacy pharmaceutical products and orphan drugs. The Company operates through three segments, which includes Legacy Pharmaceutical Division, Concordia Pharmaceuticals Inc., which consists of 23 products, including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis; Donnatal, for the treatment of irritable bowel syndrome, and Zonegran (zonisamide), for treatment of partial seizures in adults with epilepsy. Its Specialty Healthcare Distribution (SHD) Division, Complete Medical Homecare, is engaged in the distribution of medical supplies focused on diabetes and related conditions. Its Orphan Drugs Division, Concordia Laboratories Inc., is engaged in the manufacture of PHOTOFRIN.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CXRX
  • CUSIP:
Key Metrics:
  • Previous Close: $18.37
  • 50 Day Moving Average: $21.58
  • 200 Day Moving Average: $26.73
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $937.16M
  • Current Year EPS Consensus Estimate: $6.81 EPS
  • Next Year EPS Consensus Estimate: $7.73 EPS
Additional Links:
Concordia Healthcare Corp. (NASDAQ:CXRX) Chart for Wednesday, July, 27, 2016